-175- 
 
randomized controlled trial (EDITION 3). Diabetes Obes Metab . 
2015;17:386-94 
73. Rodbard HW, Visco VE, Andersen H, Hiort LC, Shu DHW. Treatment 
intensification with stepwise addition of prandial insulin aspart boluses  
compared with full basal -bolus therapy (FullSTEP Study): a randomised, 
treat-to-target clinica trial. Lancet Diabetes Endocrinol. 2014;2:30-7 
74. Hirsh IB. Insulin Analogues. N Engl J Med. 2005;352:174-83 
75. Meece, Jerry. Pancreatic Islet Dysfunction In Type 2 Diabetes: A Rational 
Target for Incretin-Based Therapies. Curr Med Res Opin. 2007;23:933-45 
76. Xu, Gang, Hideaki Kaneto, D Ross Laybutt, Valerie F Duvivier -Kalu, et al. 
Downregulation of GLPâ€“1 and GIP Receptor Expression by Hyperglycemia: 
Possible Contribution to Impaired Incretin Effects in Diabetes. Diabetes. 
2007; 56(6): 1551-9